Tamara Thomas

Urban Health Today

<p>Thomas So, PharmD, a clinical pharmacist and Sr. Manager of Consumer Drug Information Group at FDB (First Databank), discusses diabetes and diabetes &amp; obesity drugs currently on the market and related clinical research.</p>


Lou Portero

Ultra-Processed Foods Linked to Increased Ovarian and Breast Cancer Risk

Gynecologic Cancer

Low-Income Subsidy Cancer Patients Less Likely to Receive Optimal Treatment

Cancer

Midlife Metabolic Syndrome Linked to Higher Risk of Young-Onset Dementia

Alzheimer's & Dementia

Latest News

Interviews with Key Healthcare Opinion Leaders - Episode #68

Urban Health Weekly

Dr. Thomas So of First Databank discusses the new weight loss and diabetes drugs available and the clinical research behind them.

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Diabetes

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe

Interviews with Key Healthcare Opinion Leaders - Episode #68

Related Podcasts